genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2018
Endocyte
News
Novartis to Acquire Endocyte for $2.1B, Expanding RLT Pipeline in Prostate Cancer
Cancer
Endocyte Axing 40% of Workforce, Scales Back Development of Two Cancer Candidates
Cancer
Endocyte, Nihon Medi-Physics Collaborate on Companion Imaging Diagnostic
Insights
Exploiting Folate Pathways to Treat Cancer
Cancer
Endocyte Supports Oncology Studies with Medidata Clinical Cloud
Insights
People in the News
Cancer
Merck & Co. Pays Endocyte $120M for Phase III Folate Receptor-Targeting Anticancer Drug
News
Late-Stage Cancer Vaccines Set to Launch
Scroll Up
Scroll Up
